Clinical Outcomes After Progression on First-Line Therapies in IDH1 Mutated Versus Wild-Type Intrahepatic Cholangiocarcinoma Patients
Margherita Rimini, Carles Fabregat-Franco, Mara Persano, Valentina Burgio, Francesca Bergamo, Monica Niger, Mario Scartozzi, Ilario Giovanni Rapposelli, Giuseppe Aprile, Francesca Ratti, Federica Pedica, Helena Verdaguer, Mario Domenico Rizzato, Federico Nichetti, Eleonora Lai, Alessandro Cappetta, Teresa Macarulla, Matteo Fassan, Filippo de Braud, Andrea Pretta, Francesca Simionato, Francesco De Cobelli, Luca Aldrighetti, Lorenzo Fornaro, Stefano Cascinu, Andrea Casadei‐Gardini
Topics & Concepts
IDH1MedicineHazard ratioInternal medicineIsocitrate dehydrogenaseIntrahepatic CholangiocarcinomaUnivariate analysisOncologyGastroenterologyConfidence intervalMutationMultivariate analysisBiologyGeneticsGeneBiochemistryEnzymeCholangiocarcinoma and Gallbladder Cancer StudiesGallbladder and Bile Duct DisordersHepatocellular Carcinoma Treatment and Prognosis